Glucagon-like peptide-1 enhances cardiac L-type Ca2+ currents via activation of the cAMP-dependent protein kinase A pathway
2011

GLP-1 Enhances Heart Cell Calcium Currents

Sample size: 13 publication 10 minutes Evidence: moderate

Author Information

Author(s): Xiao Yong-Fu, Nikolskaya Alena, Jaye Deborah A, Sigg Daniel C

Primary Institution: Medtronic, Inc.

Hypothesis

Does glucagon-like peptide-1 (GLP-1) affect cardiac voltage-gated L-type Ca2+ currents?

Conclusion

GLP-1 enhances calcium currents in heart cells, likely through a specific signaling pathway.

Supporting Evidence

  • GLP-1 increased calcium currents by 23 ± 8%.
  • GLP-1 prolonged action potential durations significantly.
  • Effects of GLP-1 were blocked by a specific receptor antagonist when pre-applied.

Takeaway

GLP-1 helps heart cells take in more calcium, which is important for heart function.

Methodology

The study used whole-cell patch clamp techniques on isolated canine left ventricular myocytes.

Potential Biases

All authors were employees of Medtronic, which may introduce bias.

Limitations

The study did not directly measure intracellular cAMP levels.

Participant Demographics

Adult canine hearts with body weights of 30 to 33 kg were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2840-10-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication